Evaluating a Virtual Oncology Program for Veterans with Cancer
Official title: Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
Run by NYU Langone Health · NCT06559059 · Data updated 2026-11-12
This study is testing a virtual cancer care program for veterans to see if it helps them get better treatment and support for lung, colorectal, prostate, and breast cancers.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1800 (estimated) |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 5 sites (Brooklyn, New York and 4 other locations) |
| Status | Recruiting |
| Started | June 18, 2024 |
| Main results expected | May 31, 2027 |
| Study ends | July 31, 2027 |
| Registry record updated | June 3, 2026 |
| Trial ID | NCT06559059 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include veterans aged 18 and older who have been newly diagnosed with lung, prostate, breast, or colon cancer within three months of their telemedicine visit.
✕Probably not a fit
Patients who have not engaged with VA providers in the past year or those with a prior diagnosis of the specified cancers will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the effectiveness of the VA National TeleOncology program, a telehealth initiative designed to improve cancer care for veterans diagnosed with lung, colorectal, prostate, and breast cancers. By utilizing the Veterans Health Information Systems and Technology Architecture (VistA), the study will identify eligible patients and analyze their telehealth engagement, clinical quality, and healthcare costs. The focus is on understanding how social determinants affect telehealth access and outcomes, ultimately promoting health equity among veterans.
Why it matters
Potential benefit: If successful, this program could enhance cancer care delivery and accessibility for veterans, leading to improved health outcomes.
How similar studies have gone: Other studies have shown promising results with telehealth interventions in oncology, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Patients Inclusion Criteria: 1. A Veteran 2. Aged 18 years or older 3. Newly diagnosed with lung, prostate, breast, or colon cancer within 3 months of telemedicine visit 4. Engaged in an oncology visit during the 36-month analysis period at a Veterans Affairs Medical Center (VAMC) location. VAMC Providers and Staff Inclusion Criteria: 1. Provider or staff member at one of the VAMC locations including physicians, nurse practitioners, physicians' assistants, and nurses caring for Veterans 2. Providers or staff members having helped provide care for at least 5 Veterans with cancer in the previous 6 months at a VAMC location Patients Exclusion Criteria: 1. Veterans who have not seen any providers in the VA within the past year 2. Patients previously diagnosed with lung, prostate, breast, or colon cancer 3. Pregnant patients VAMC Providers and Staff Exclusion Criteria: 1\. Providers or staff members who do not help treat Veterans with specified cancers in oncology at the VA
Where it's running
-
VA New York Harbor Healthcare System - Brooklyn
Brooklyn, New York, United States Recruiting -
VA New York Harbor Healthcare System - St. Albans Community Living Center
Jamaica, New York, United States Recruiting -
VA New York Harbor Health Care System - Manhattan
New York, New York, United States Recruiting -
VA New York Harbor Healthcare System - Harlem Community Center
New York, New York, United States Recruiting -
VA New York Harbor Healthcare System - Staten Island Community Clinic
Staten Island, New York, United States Recruiting
Study contacts
- Principal investigator: Danil Makarov, MD, MHS — NYU Langone Health
- Study coordinator: Janeth Juarez Padilla
- Email: Janeth.juarezpadilla@nyulangone.org
- Phone: 646-501-3588
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Boosting lung cancer screening for patients seen in the emergency department
This project will test whether giving eligible emergency department patients a facilitated referral plus text reminders helps more people get lung cancer screening.
-
Parastomal Hernia After Colorectal Cancer Surgery: Do Radiology Findings Match Quality of Life
We’re testing how often parastomal hernias appear and change on CT scans after colorectal cancer surgery with a permanent end colostomy, and whether these findings relate to patients’ quality of life.
-
ctDNA blood test to spot buried cancer after surgery or treatment in colorectal cancer
A blood test that looks for specific KRAS mutations in circulating tumor DNA to see if colorectal cancer has left residual disease or is likely to relapse.
-
68Ga-XMFH01 PET/FL imaging to guide prostate cancer surgery
This study tests a new dual-modality imaging probe, 68Ga-XMFH01, to preoperatively detect prostate cancer and guide the surgeon with fluorescence during operations in adults with newly diagnosed prostate cancer.
-
Hugo Robotic Prostatectomy in an Ambulatory Surgery Center
This study tests the use of the Hugo robotic system for prostate removal in adult men treated at an outpatient surgical center.
-
Adaptive intraoperative biopsy system for prostate cancer using imaging and metabolic feedback
Aiming to test a smart biopsy approach that combines preoperative imaging with real-time metabolic signals to guide where to take prostate biopsy cores for better precision in men suspected of prostate cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.